Join the Breast Cancer - Male group to help and get support from people like you.
Breast Cancer - Male News
SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations
THURSDAY, Dec. 12, 2024 – For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, imlunestrant leads to significantly...
U.S. Breast Cancer Deaths Keep Declining, Though Disparities Remain
TUESDAY, Oct. 1, 2024 – While women overall are less likely to die of breast cancer now, some alarming disparities remain, a new American Cancer Society (ACS) analysis warns. Death rates for...
American Indian/Alaska Native Breast Cancer Patients Less Likely to Get Reconstruction
MONDAY, July 8, 2024 — After a mastectomy, some women are less likely than others to have breast reconstruction surgery. Rates of the surgery are consistently lower among American Indian and Alaskan n...
FDA Approves Piqray (alpelisib) as First PI3K Inhibitor for Breast Cancer
May 24, 2019 -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat ...
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
April 4, 2019 – Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to expand the indications for Ibrance...